Key Financial Data Of Reporting Company

SAPPORO CLINICAL LABORATORY INC. - Filing #7247539

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
20,131,372,000 JPY
17,944,882,000 JPY
17,333,697,000 JPY
19,682,319,000 JPY
17,613,669,000 JPY
20,127,692,000 JPY
17,737,144,000 JPY
19,109,595,000 JPY
16,372,822,000 JPY
17,502,544,000 JPY
Ordinary profit (loss)
707,979,000 JPY
718,706,000 JPY
598,333,000 JPY
514,777,000 JPY
895,308,000 JPY
1,159,449,000 JPY
1,567,931,000 JPY
1,605,618,000 JPY
1,170,964,000 JPY
1,188,144,000 JPY
Profit (loss)
476,351,000 JPY
460,452,000 JPY
471,722,000 JPY
1,024,167,000 JPY
791,119,000 JPY
Share capital
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
Total number of issued shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
Net assets
11,394,115,000 JPY
10,869,185,000 JPY
11,183,039,000 JPY
10,640,704,000 JPY
10,212,467,000 JPY
10,880,986,000 JPY
10,337,959,000 JPY
9,839,022,000 JPY
9,272,384,000 JPY
9,014,231,000 JPY
Total assets
16,450,937,000 JPY
15,031,899,000 JPY
16,680,947,000 JPY
15,057,391,000 JPY
14,487,068,000 JPY
16,521,281,000 JPY
16,149,449,000 JPY
14,440,322,000 JPY
14,511,471,000 JPY
13,662,749,000 JPY
Net assets per share
3,575.27
3,484.01
3,283.71
3,194.85
3,066.27
3,178.25
3,016.24
2,934.15
2,708.63
2,633.22
Dividend paid per share
23
23
23
23
23
Interim dividend paid per share
Basic earnings (loss) per share
148.35
152.24
138.25
114.14
141.47
170.53
300.67
306.16
231.10
231.85
Diluted earnings per share
Equity-to-asset ratio
0.678 xbrli:pure
0.723 xbrli:pure
0.656 xbrli:pure
0.707 xbrli:pure
0.705 xbrli:pure
0.641 xbrli:pure
0.626 xbrli:pure
0.681 xbrli:pure
0.639 xbrli:pure
0.660 xbrli:pure
Rate of return on equity
0.042 xbrli:pure
0.044 xbrli:pure
0.044 xbrli:pure
0.035 xbrli:pure
0.047 xbrli:pure
0.055 xbrli:pure
0.109 xbrli:pure
0.108 xbrli:pure
0.092 xbrli:pure
0.090 xbrli:pure
Price-earnings ratio
6.61 xbrli:pure
6.44 xbrli:pure
7.86 xbrli:pure
9.51 xbrli:pure
8.96 xbrli:pure
7.43 xbrli:pure
4.31 xbrli:pure
4.23 xbrli:pure
6.63 xbrli:pure
6.61 xbrli:pure
Payout ratio
0.151 xbrli:pure
0.166 xbrli:pure
0.163 xbrli:pure
0.076 xbrli:pure
0.100 xbrli:pure
Net cash provided by (used in) operating activities
730,911,000 JPY
1,077,593,000 JPY
1,430,350,000 JPY
1,573,628,000 JPY
837,590,000 JPY
Net cash provided by (used in) investing activities
-1,240,168,000 JPY
-395,474,000 JPY
-409,028,000 JPY
-830,960,000 JPY
-3,148,264,000 JPY
Net cash provided by (used in) financing activities
-525,743,000 JPY
-369,961,000 JPY
-347,894,000 JPY
-112,738,000 JPY
1,943,634,000 JPY
Cash and cash equivalents
2,931,206,000 JPY
3,966,205,000 JPY
3,654,048,000 JPY
2,980,620,000 JPY
2,350,691,000 JPY
Number of employees
3 xbrli:pure
533 xbrli:pure
315 xbrli:pure
303 xbrli:pure
21 xbrli:pure
19 xbrli:pure
879 xbrli:pure
303 xbrli:pure
3 xbrli:pure
642 xbrli:pure
21 xbrli:pure
871 xbrli:pure
635 xbrli:pure
627 xbrli:pure
938 xbrli:pure
871 xbrli:pure
622 xbrli:pure
819 xbrli:pure
775 xbrli:pure
Total shareholder return
0.685 xbrli:pure
0.737 xbrli:pure
0.836 xbrli:pure
0.840 xbrli:pure
0.973 xbrli:pure
Total return on share price index
2.134 xbrli:pure
2.168 xbrli:pure
1.534 xbrli:pure
1.450 xbrli:pure
1.421 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.